Covetrus Announces CEO and Chairman Transition

Benjamin Shaw steps down as CEO and president and will serve as a strategic advisor to the board of Covetrus. Board chair Wolin to assume role as acting CEO and president, lead independent director Laskawy to serve as board chair.

PORTLAND, MaineOctober 22, 2019 – Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Benjamin Shaw has stepped down as the company’s president and chief executive officer and will transition to a strategic advisor to the board. Benjamin Wolin, who currently serves as the company’s chair of the board, will assume the role of acting CEO and president. Philip A. Laskawy, the board’s lead independent director, will take over as board chair. Read more

Related Posts

University of Maine recruiting homeowners for tick surveys

ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...

25 April 2023

Maine’s oldest bioscience symposium turns 50 on MDI

Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...

23 April 2023

Husson University students, faculty share projects at 13th annual Research Showcase

BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...

20 April 2023